L00_Intro |
1 |
L01_NB_Broadening the therapeutic band width |
5 |
L02_MS_Dose algorithms |
56 |
L03_NB_ICRU planning and prescribing |
94 |
L04_MS_nonIMRT |
178 |
L05_ND_Relationships between 3D dose distributions and clinical toxicities (H&N and Pelvis) |
222 |
L06_DvB_Planning Aspects Breast Cancer |
304 |
L07_DvB_Breast case |
389 |
L08_UN_Relationships between 3D dose distributions and clinical toxicities - Chest |
427 |
L09_GM_Practical aspects of IMRT planning1 |
474 |
L10_MS_Practical aspects IMRT_part 2 |
511 |
L11_MvH_Geometric uncertainties and how to deal with them |
547 |
L12_MS_Particle therapy planning |
588 |
L13_MS-NB_Brain case |
631 |
L14_GM_Basic principles of rotational IMRT planning |
657 |
L15_MvH_adaptive planing strategies |
691 |
L16_ND_MRI in treatment planning |
723 |
L17_UN_Advanced planning strategies lung cancer |
784 |
L18_GM_Physical and biological optimisation |
822 |
L19_UN_Lung case |
846 |
L20_UN_Molecular imaging ATP |
854 |
L21_GM_Library planning |
890 |
L22_MvH_Robust and probabilistic planning |
917 |
L23_GM_Dose painted planning |
942 |
L24_MvH_Rigid and deformable registration |
967 |
L25_ND_Introduction Case 4 Bilateral oropharaynx |
998 |
L26_MS_Pareto front |
1041 |
L27_GM_Physicist's perspective |
1077 |
L28_NB_Doctor's perspective |
1115 |